All sexually active women aged 15-24 should be screened for genital infection with Chlamydia trachomatis at least yearly. Prevalence in this group ranges from 1% 2% in some parts of the country to 15%-18% in others. Some experts advise screening every 6 months in high prevalence areas.
Older women who are sexually active with multiple partners and adolescent and young adult males should also be screened periodically. This has been made easier in the last year with the availability of urine screens.
Treatment is fairly straightforward. There are two equally effective, first-line rugs for nonpregnant patients: azithromycin is given as a single dose; doxycycline is much cheaper. Other treatment options are generally considered second-line alternatives.
The recommended drugs and dosages are the same for postpubescent patients of all ages, both females and males.
For pregnant patients, doxycycline and ofloxacin are contraindicated. Azithromycin is widely used to treat pregnant women even though it is not approved for use during pregnancy.
COPYRIGHT 2000 International Medical News Group
COPYRIGHT 2001 Gale Group